# Multiple Dose ASM8 in Mild Asthmatics

> **NCT00264966** · PHASE1,PHASE2 · COMPLETED · sponsor: **Syntara** · enrollment: 15 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ASM8

## Key facts

- **NCT ID:** NCT00264966
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 15 (—)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264966, "Multiple Dose ASM8 in Mild Asthmatics". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00264966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*